The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity

The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity

Objectives: To evaluate the utility of intrapartum amnioinfusion (AI) in reducing the infectious morbidity of patients with meconium-stained fluid (MSF). Previous studies have shown increased intraamniotic infection (IAI) and postpartum endometritis (PPE) rates in patients with MSF. Intraamniotic in...

Full description

Bibliographic Details
Main Authors: C. D. Adair, J. W. Weeks, G. Johnson, S. Burlison, S. London, D. F. Lewis
Format: Article
Language:English
Published: Hindawi Limited 1997-01-01
Series:Infectious Diseases in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/S1064744997000665
id doaj-77a68a02625344cbafbbad35074c0b18
record_format Article
spelling doaj-77a68a02625344cbafbbad35074c0b182020-11-24T22:10:01ZengHindawi LimitedInfectious Diseases in Obstetrics and Gynecology1064-74491098-09971997-01-015636636910.1155/S1064744997000665The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious MorbidityC. D. Adair0J. W. Weeks1G. Johnson2S. Burlison3S. London4D. F. Lewis5Department of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USADepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USADepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USADepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USADepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USADepartment of Obstetrics and Gynecology, Louisiana State University Medical Center, P.O. Box 33932, 1501 Kings Highway, Shreveport, LA, USAObjectives: To evaluate the utility of intrapartum amnioinfusion (AI) in reducing the infectious morbidity of patients with meconium-stained fluid (MSF). Previous studies have shown increased intraamniotic infection (IAI) and postpartum endometritis (PPE) rates in patients with MSF. Intraamniotic infection has been reduced with the prophylactic administration of ampicillin–sulbactam in MSF. Intraamniotic infection and PPE have been reduced with the use of AI in patients with clear fluid. No investigators have specifically examined the efficacy of AI in reducing meconium-stained, amniotic-fluid-associated infectious morbidity.http://dx.doi.org/10.1155/S1064744997000665
collection DOAJ
language English
format Article
sources DOAJ
author C. D. Adair
J. W. Weeks
G. Johnson
S. Burlison
S. London
D. F. Lewis
spellingShingle C. D. Adair
J. W. Weeks
G. Johnson
S. Burlison
S. London
D. F. Lewis
The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
Infectious Diseases in Obstetrics and Gynecology
author_facet C. D. Adair
J. W. Weeks
G. Johnson
S. Burlison
S. London
D. F. Lewis
author_sort C. D. Adair
title The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
title_short The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
title_full The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
title_fullStr The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
title_full_unstemmed The Utility of Amnioinfusion in the Prophylaxis of Meconium-Stained Amniotic Fluid Infectious Morbidity
title_sort utility of amnioinfusion in the prophylaxis of meconium-stained amniotic fluid infectious morbidity
publisher Hindawi Limited
series Infectious Diseases in Obstetrics and Gynecology
issn 1064-7449
1098-0997
publishDate 1997-01-01
description Objectives: To evaluate the utility of intrapartum amnioinfusion (AI) in reducing the infectious morbidity of patients with meconium-stained fluid (MSF). Previous studies have shown increased intraamniotic infection (IAI) and postpartum endometritis (PPE) rates in patients with MSF. Intraamniotic infection has been reduced with the prophylactic administration of ampicillin–sulbactam in MSF. Intraamniotic infection and PPE have been reduced with the use of AI in patients with clear fluid. No investigators have specifically examined the efficacy of AI in reducing meconium-stained, amniotic-fluid-associated infectious morbidity.
url http://dx.doi.org/10.1155/S1064744997000665
work_keys_str_mv AT cdadair theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT jwweeks theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT gjohnson theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT sburlison theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT slondon theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT dflewis theutilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT cdadair utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT jwweeks utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT gjohnson utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT sburlison utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT slondon utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
AT dflewis utilityofamnioinfusionintheprophylaxisofmeconiumstainedamnioticfluidinfectiousmorbidity
_version_ 1725809619038633984

Similar Items